The company “Nanopharma Development” and “Izvarino Pharma” (Moscow) together with representatives of the company BOSСH carried out the first launch of the equipment for the production of pharmaceutical preparations. The results of the tests showed that the equipment is ready for production and is fully operational. According to the company, this is the first step to start the production of pharmaceuticals.
The project on creation of drugs for the treatment of cancer, HIV infection, and drugs needed for the transplant of organs was initiated by LLC “Izvarino Pharma” and Technopark “Idea”. The agreement on project implementation was signed in November 2013. In December 2015, the founders of the company “Izvarino Pharma” made a decision on early redemption of assets.
The project focuses on the development of medicinal products based on the use of nanoparticles - it delivers molecules of the active substance “precisely” in the right body that allows to minimize side effects and increase the effectiveness of drugs. Another direction of the project is to develop and manufacture drugs for the treatment of cancer, drugs used in transplantation and in diseases accompanying HIV infection. At the moment, there have already been developed and submitted for the state registration a drug for the treatment of leukemia “Imatinib” and “Tacrolimus” - a tool needed for therapy after transplantation of organs and tissues. In total, there will be made up to 10 innovative products within the framework of the project. An automated production line, which does not require contact personnel with drugs, was purchased with the support of the Nanotechnology Center for this project.
Recall that on March 26, 2010 there were announced the results of the first open competition on selection of projects of nanotechnology centers creation, which was conducted by State Corporation “Rusnanotech" (JSC “RUSNANO”). The collective application of Innovative Technopark “Idea” entered into number of winners, and Technopark received the right to conclude an investment agreement with “RUSNANO” on the implementation of the project to create the Nanotechnology Center. The company “Izvarino Pharma” acted together with Technopark at the stage of order formation. Pharmaceutical company and Technopark “Idea” developed an anchor for the Nanotechnology Center project – “Nanopharma Development”.
